• Press Releases August 16, 2024

    NOWDiagnostics First To Know Syphilis Test Receives FDA De Novo Marketing Authorization for Over-the-Counter Use

    First and only rapid syphilis test with in-home results in minutes, addressing growing epidemic SPRINGDALE, ARK. – August 16, 2024 – NOWDiagnostics, Inc. (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostic tests, today announced that the U.S. Food and Drug Administration (FDA) has granted marketing authorization to its First To Know® Syphilis Test for…

    Read More